Hypofractionated stereotactic radiosurgery with concurrent chemotherapy for recurrent head and neck squamous cell carcinoma (RH&NSCC)

Authors :: K. Lassi
Bruce J. Davidson
Kenneth Newkirk
A. K. Esnakula
Jimmy J. Hwang
K.W. Harter
E. Bischoff
John F. Deeken
Source :: Journal of Clinical Oncology. 26:17041-17041
Publication Year :: 2008
Publisher :: American Society of Clinical Oncology (ASCO), 2008.
Abstract: 17041 Background: The prognosis of patients with RH&NSCC remains dismal, with a median survival of 4 months without treatment and 6 months with palliative chemotherapy. Surgery remains the best tre...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
endocrine system diseases
business.industry
medicine.medical_treatment
Palliative chemotherapy
medicine.disease
Head and neck squamous-cell carcinoma
Radiosurgery
Concurrent chemotherapy
Internal medicine
medicine
business
Median survival

Full Text Access

Tools